Provided by Tiger Fintech (Singapore) Pte. Ltd.

NLS Pharmaceutics Ltd.

2.57
-0.2900-10.14%
Post-market: 2.600.0300+1.17%19:56 EDT
Volume:448.46K
Turnover:1.08M
Market Cap:9.25M
PE:-0.39
High:2.70
Open:2.34
Low:2.16
Close:2.86
Loading ...
Dec 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 10, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Mar 24, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 24, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 20, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Nov 01, 2021

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Nov 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 22, 2021

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Oct 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 14, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 25, 2021

Correspondence

CORRESP [Cover] - Correspondence